GlassScriptPhysician profile
Stacy Roskin
NPI 1669530218
$9,003.41
in general payments reported to CMS, 2019-2025
47 companies · $1,615 in 2025
The $1,615 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $116 · 2021: $1,422 · 2022: $1,655 · 2023: $1,831 · 2024: $1,549 · 2025: $1,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,900 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,899.72 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,091.98 | 2019-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $940.95 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $662.29 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $640.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $541.56 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $497.72 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.07 | 2019-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $454.56 | 2023-2025 | Gemtesa |
| Radius Health, INC. | $355.80 | 2019-2025 | Tymlos |
| Novo Nordisk INC | $324.47 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astellas Pharma US INC | $290.05 | 2019-2025 | Myrbetriq, Veozah |
| Novartis Pharmaceuticals Corporation | $281.73 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $279.94 | 2019-2023 | |
| Abbvie INC. | $278.41 | 2021-2025 | |
| Heartflow, INC. | $171.43 | 2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Roskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.